Author:
Esteva D.,Muros M. A.,Llamas-Elvira J. M.,Jiménez Alonso J.,Villar J. M.,López de la Torre M.,Muros T.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007;1357–61.
2. Grünwald F, Diehl M. Thyroid carcinomas. In: Oehr P, Biersack HJ, Coleman RE, editors. PET and PET-CT in oncology. Germany: Springer-Verlag Berlin Heidelberg; 2004. p. 137–48.
3. Cady B. Papillary carcinoma of the thyroid gland: treatment based on risk group definition. Surg Oncol Clin North Am. 1998;7:633–44.
4. Hay ID, Thompson GB, Grant CS, Bergstalh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879–85.
5. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–8.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献